Regulation of Neprilysin Activity and Cognitive Functions in Rats After Prenatal Hypoxia
The amyloid-degrading enzyme neprilysin (NEP) is one of the therapeutic targets in prevention and treatment of Alzheimer’s disease (AD). As we have shown previously NEP expression in rat parietal cortex (Cx) and hippocampus (Hip) decreases with age and is also significantly reduced after prenatal hypoxia. Following the paradigms for enhancement of NEP expression and activity developed in cell culture, we analysed the efficacy of various compounds able to upregulate NEP using our model of prenatal hypoxia in rats. In addition to the previous data demonstrating that valproic acid can upregulate NEP expression both in neuroblastoma cells and in rat Cx and Hip we have further confirmed that caspase inhibitors can also restore NEP expression in rat Cx reduced after prenatal hypoxia. Here we also report that administration of a green tea catechin epigallocatechin-3-gallate (EGCG) to adult rats subjected to prenatal hypoxia increased NEP activity in blood plasma, Cx and Hip as well as improved memory performance in the 8-arm maze and novel object recognition tests. Moreover, EGCG administration led to an increased number of dendritic spines in the hippocampal CA1 area which correlated with memory enhancement. The data obtained allowed us to conclude that the decrease in the activity of the amyloid-degrading enzyme NEP, as well as a reduction in the number of labile interneuronal contacts in the hippocampus, contribute to early cognitive deficits caused by prenatal hypoxia and that there are therapeutic avenues to restore these deficits via NEP activation which could also be used for designing preventive strategies in AD.
KeywordsAlzheimer’s disease Neprilysin Novel object recognition test Prenatal hypoxia Epigallocatechin gallate (EGCG) Dendritic spines
Authors express their deepest gratitude to Prof Anthony J Turner for long-lasting collaboration and scientific guidance.
Supported by Russian Foundation for Basic Research (RFFI-19-015-00232) and Russian state budget (assignment AAAA-A18-118012290373-7).
Compliance with Ethical Standards
Conflict of interest
Authors declare no conflict of interest.
All current international, national, and institutional guidelines for the care and use of experimental animals were followed.
- 15.Nalivaeva NN, Belyaev ND, Zhuravin IA, Turner AJ (2012) The Alzheimer’s amyloid-degrading peptidase, neprilysin: can we control it? Int J Alzheimers Dis 2012:383796Google Scholar
- 18.Dubrovskaia NM, Nalivaeva NN, Plesneva SA, Feponova AA, Turner AJ, Zhuravin IA (2009) Changes in the activity of amyloid-degrading metallopeptidases leads to disruption of memory in rats. Zh Vyssh Nerv Deiat Im I P Pavlova 59:630–638Google Scholar
- 20.Zhuravin IA, Dubrovskaya NM, Tumanova NL, Vasilev DS, Nalivaeva NN (2018) Ontogenetic and phylogenetic approaches for studying the mechanisms of cognitive dysfunctions. In: Levchenko VF (ed) Evolutionary. Physiology and Biochemistry Advances and Perspectives. Norderstedt, InTech, pp 205–224Google Scholar
- 24.Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, Ring S, D’Adamio L, Shen J, Müller U, St George Hyslop P, Checler F (2005) Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP. Neuron 46:541–554CrossRefGoogle Scholar
- 25.Belyaev ND, Kellett KA, Beckett C, Makova NZ, Revett TJ, Nalivaeva NN, Hooper NM, Turner AJ (2010) The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a β-secretase-dependent pathway. J Biol Chem 285:41443–41454CrossRefGoogle Scholar
- 33.Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, San Diego, p 474Google Scholar
- 52.Yamamoto N, Shibata M, Ishikuro R, Tanida M, Taniguchi Y, Ikeda-Matsuo Y et al (2017) Epigallocatechin gallate induces extracellular degradation of amyloid β-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3 K pathways. Neuroscience 362:70–78CrossRefGoogle Scholar
- 59.Fujiki H, Watanabe T, Sueoka E, Rawangkan A, Suganuma M (2018) Cancer prevention with green tea and its principal constituent, EGCG: from early investigations to urrent docus on human cancer stem cells. Mol Cells 41:73–82Google Scholar